Literature DB >> 33482740

Prognosis tools for short-term adverse events in older emergency department users: result of a Québec observational prospective cohort.

Cyrille P Launay1,2, Joshua Lubov3, Kevin Galery3,4, Christine Vilcocq3,4, Éric Maubert3,4, Marc Afilalo5, Olivier Beauchet3,6,7.   

Abstract

BACKGROUND: The "Program of Research on the Integration of Services for the Maintenance of Autonomy" (PRISMA-7) and "Emergency room evaluation and recommendations" (ER2) are both clinical tools used in Québec Emergency Departments (EDs) for screening of older ED users at higher risk of poor outcomes, such as prolonged length of stay (LOS) in EDs and in hospital. The study aimed to: 1) examine whether the PRISMA-7 and ER2 risk levels were associated with length of stays in ED and hospital, as well as hospital admission; and 2) compare the criteria performance (i.e., sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratios and area under receiver operating characteristic curve) of the PRISMA-7 and ER2 high-risk levels for these three ED adverse events in Québec older patients visiting ED on a stretcher.
METHODS: A total of 1905 older patients who visited the ED of the Jewish General Hospital (Montreal, Québec, Canada) on stretchers were recruited in this prospective observational cohort. Upon their ED arrival, PRISMA-7 and ER2 were performed. The outcomes were LOS in ED and in hospital, and hospital admission.
RESULTS: The PRISMA-7 and ER2 risk levels were associated with length of stay in ED and hospital as well as with hospital admission. Prolonged stays and higher hospitalization rates were associated with high-risk levels, whereas those in low-risk level groups had significantly shorter LOS and a lower rate of hospital admission (P < 0.006). While performance measures were poor for both assessment tools, ER2 had a greater prognostic testing accuracy compared with PRISMA-7.
CONCLUSION: PRISMA-7 and ER2 were both associated with incidental short-term ED adverse events but their overall prognostic testing accuracy was low, suggesting that they cannot be used as prognostic tools for this purpose.

Entities:  

Keywords:  Adverse event; Emergency department; Older adults; Prognosis

Mesh:

Year:  2021        PMID: 33482740      PMCID: PMC7821522          DOI: 10.1186/s12877-020-01999-6

Source DB:  PubMed          Journal:  BMC Geriatr        ISSN: 1471-2318            Impact factor:   3.921


  25 in total

1.  Mobile geriatric team and length of hospital stay among older inpatients: a case-control pilot study.

Authors:  Cyrille Launay; Laure de Decker; Raphael Hureaux-Huynh; Cedric Annweiler; Olivier Beauchet
Journal:  J Am Geriatr Soc       Date:  2012-08       Impact factor: 5.562

2.  Research priorities for high-quality geriatric emergency care: medication management, screening, and prevention and functional assessment.

Authors:  Christopher R Carpenter; Kennon Heard; Scott Wilber; Adit A Ginde; Kirk Stiffler; Lowell W Gerson; Neal S Wenger; Douglas K Miller
Journal:  Acad Emerg Med       Date:  2011-06       Impact factor: 3.451

3.  Update of the 6-Item Brief Geriatric Assessment Screening Tool of Older Inpatients at Risk for Long Length of Hospital Stay: Results From a Prospective and Observational Cohort Study.

Authors:  Olivier Beauche; Julia Chabot; Shek Fung; Cyrille P Launay
Journal:  J Am Med Dir Assoc       Date:  2018-04-26       Impact factor: 4.669

4.  Screening for elderly patients admitted to the emergency department requiring specialized geriatric care.

Authors:  Olivier Beauchet; Cyrille P Launay; Bruno Fantino; Nicolas Lerolle; Franck Maunoury; Cédric Annweiler
Journal:  J Emerg Med       Date:  2013-06-05       Impact factor: 1.484

5.  Emergency Department Interventions for Older Adults: A Systematic Review.

Authors:  Jaime M Hughes; Caroline E Freiermuth; Megan Shepherd-Banigan; Luna Ragsdale; Stephanie A Eucker; Karen Goldstein; S Nicole Hastings; Rachel L Rodriguez; Jessica Fulton; Katherine Ramos; Amir Alishahi Tabriz; Adelaide M Gordon; Jennifer M Gierisch; Andrzej Kosinski; John W Williams
Journal:  J Am Geriatr Soc       Date:  2019-03-15       Impact factor: 5.562

6.  Rapid two-stage emergency department intervention for seniors: impact on continuity of care.

Authors:  Jane McCusker; Nandini Dendukuri; Pierre Tousignant; Josée Verdon; Louise Poulin de Courval; Eric Belzile
Journal:  Acad Emerg Med       Date:  2003-03       Impact factor: 3.451

7.  PRISMA-7: a case-finding tool to identify older adults with moderate to severe disabilities.

Authors:  Michel Raîche; Réjean Hébert; Marie-France Dubois
Journal:  Arch Gerontol Geriatr       Date:  2007-08-27       Impact factor: 3.250

8.  Screening for risk of readmission of patients aged 65 years and above after discharge from the emergency department: predictive value of four instruments.

Authors:  Philip Moons; Koen De Ridder; Katrien Geyskens; Marc Sabbe; Tom Braes; Johan Flamaing; Koen Milisen
Journal:  Eur J Emerg Med       Date:  2007-12       Impact factor: 2.799

9.  Impact of PRISMA, a coordination-type integrated service delivery system for frail older people in Quebec (Canada): A quasi-experimental study.

Authors:  Réjean Hébert; Michel Raîche; Marie-France Dubois; N'Deye R Gueye; Nicole Dubuc; Michel Tousignant
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-05-04       Impact factor: 4.077

10.  Why do older people with multi-morbidity experience unplanned hospital admissions from the community: a root cause analysis.

Authors:  Richard L Reed; Linda Isherwood; David Ben-Tovim
Journal:  BMC Health Serv Res       Date:  2015-11-27       Impact factor: 2.655

View more
  1 in total

1.  Emergency Room Evaluation and Recommendations and Risk Screening of Incident Major Neurocognitive Disorders in Older Females: Results of an Observational Population-Based Cohort Study.

Authors:  Olivier Beauchet; Jacqueline Matskiv; Cyrille P Launay; Yves Rolland; Anne-Marie Schott; Gilles Allali
Journal:  Front Aging Neurosci       Date:  2022-07-22       Impact factor: 5.702

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.